Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.

Angerer V, Jacobi S, Franz F, Auwärter V, Pietsch J.

Forensic Sci Int. 2017 Dec;281:e9-e15. doi: 10.1016/j.forsciint.2017.10.042. Epub 2017 Nov 7.

PMID:
29133010
2.

Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.

Hermanns-Clausen M, Müller D, Kithinji J, Angerer V, Franz F, Eyer F, Neurath H, Liebetrau G, Auwärter V.

Clin Toxicol (Phila). 2017 Oct 26:1-8. doi: 10.1080/15563650.2017.1393082. [Epub ahead of print]

PMID:
29072524
3.

Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System.

Cannaert A, Franz F, Auwärter V, Stove CP.

Anal Chem. 2017 Sep 5;89(17):9527-9536. doi: 10.1021/acs.analchem.7b02552. Epub 2017 Aug 18.

PMID:
28771321
4.

Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.

Mogler L, Franz F, Rentsch D, Angerer V, Weinfurtner G, Longworth M, Banister SD, Kassiou M, Moosmann B, Auwärter V.

Drug Test Anal. 2017 Mar 31. doi: 10.1002/dta.2201. [Epub ahead of print]

PMID:
28371476
5.

Analysis of risk prediction capability and validity of Morse Fall Scale Brazilian version.

Urbanetto JS, Pasa TS, Bittencout HR, Franz F, Rosa VP, Magnago TS.

Rev Gaucha Enferm. 2017 Feb 16;37(4):e62200. doi: 10.1590/1983-1447.2016.04.62200. Portuguese, English.

6.

Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.

Franz F, Angerer V, Jechle H, Pegoro M, Ertl H, Weinfurtner G, Janele D, Schlögl C, Friedl M, Gerl S, Mielke R, Zehnle R, Wagner M, Moosmann B, Auwärter V.

Clin Chem Lab Med. 2017 Aug 28;55(9):1375-1384. doi: 10.1515/cclm-2016-0831.

PMID:
28130957
7.
8.

Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay.

Cannaert A, Storme J, Franz F, Auwärter V, Stove CP.

Anal Chem. 2016 Dec 6;88(23):11476-11485. Epub 2016 Nov 7.

9.

Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.

Franz F, Angerer V, Moosmann B, Auwärter V.

Drug Test Anal. 2017 May;9(5):744-753. doi: 10.1002/dta.2049. Epub 2016 Sep 21.

PMID:
27504870
10.

The Transcriptional Regulation of FOXO Genes in Thyrocytes.

Franz F, Weidinger C, Krause K, Gimm O, Dralle H, Führer D.

Horm Metab Res. 2016 Sep;48(9):601-6. doi: 10.1055/s-0042-105153. Epub 2016 Jun 3.

PMID:
27258970
11.

Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?

Franz F, Angerer V, Hermanns-Clausen M, Auwärter V, Moosmann B.

Anal Bioanal Chem. 2016 May;408(13):3445-52. doi: 10.1007/s00216-016-9422-2. Epub 2016 Mar 2.

PMID:
26935933
12.

In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.

Franz F, Angerer V, Brandt SD, McLaughlin G, Kavanagh PV, Moosmann B, Auwärter V.

Drug Test Anal. 2017 Feb;9(2):311-316. doi: 10.1002/dta.1950. Epub 2016 Feb 17.

PMID:
26888282
13.

Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA'.

Angerer V, Franz F, Schwarze B, Moosmann B, Auwärter V.

J Anal Toxicol. 2016 Apr;40(3):240-2. doi: 10.1093/jat/bkw004. Epub 2016 Jan 27. No abstract available.

14.

Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.

Hermanns-Clausen M, Kithinji J, Spehl M, Angerer V, Franz F, Eyer F, Auwärter V.

Drug Test Anal. 2016 Oct;8(10):1030-1038. doi: 10.1002/dta.1936. Epub 2016 Jan 15.

PMID:
26768345
15.

Reduction of clinically irrelevant alarms in patient monitoring by adaptive time delays.

Schmid F, Goepfert MS, Franz F, Laule D, Reiter B, Goetz AE, Reuter DA.

J Clin Monit Comput. 2017 Feb;31(1):213-219. doi: 10.1007/s10877-015-9808-2. Epub 2015 Nov 30.

PMID:
26621389
16.

[Morse Fall Scale: translation and transcultural adaptation for the Portuguese language].

de Urbanetto JS, Creutzberg M, Franz F, Ojeda BS, da Gustavo AS, Bittencourt HR, Steinmetz QL, Farina VA.

Rev Esc Enferm USP. 2013 Jun;47(3):569-75. Portuguese.

PMID:
24601131
17.

A new management for limb graft occlusion after endovascular aneurysm repair adding a vollmar ring stripper: the unclogging technique.

Ronsivalle S, Faresin F, Franz F, Pedon L, Rettore C, Zonta L, Olivieri A.

Ann Vasc Surg. 2013 Nov;27(8):1216-22. doi: 10.1016/j.avsg.2013.02.018. Epub 2013 Sep 5.

PMID:
24011815
18.

Differential effects of cognitive inhibition and intelligence on creativity.

Benedek M, Franz F, Heene M, Neubauer AC.

Pers Individ Dif. 2012 Sep;53-334(4):480-485.

19.

Influence of adhesive point dimension and splint type on splint rigidity--evaluation by the dynamic Periotest method.

Franz F, Potapov S, Petschelt A, Berthold C.

Dent Traumatol. 2013 Jun;29(3):203-11. doi: 10.1111/j.1600-9657.2012.01164.x. Epub 2012 Jul 22.

PMID:
22816496
20.

Type II endoleak: from treatment of a complication to prevention.

Ronsivalle S, Faresin F, Franz F, Rettore C, Zanchetta M, Olivieri A.

J Endovasc Ther. 2012 Feb;19(1):128-9. doi: 10.1583/11-3691L.1. No abstract available.

PMID:
22313214

Supplemental Content

Loading ...
Support Center